B7-H3 has also been found to serve as an enrichment surface marker for Bmi1+ HNSCC CSCs, and anti-B7-H3 antibodies eliminated the CSC population and inhibited tumor growth in a CD8+ T-cell-dependent manner [80]. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.